Small intestine cancer statistics

Cases

New cases of small intestine cancer, 2017-2019, UK

 

Deaths

Deaths from small intestine cancer, 2017-2019, UK.

 

Survival

Survive small intestine cancer for 5 or more years, 2016-2020, England

  • There are around 1,900 new small intestine cancer cases in the UK every year, that's more than 5 every day (2017-2019).
  • Small intestine cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017-2019).
  • In females in the UK, small intestine cancer is not among the 20 most common cancers, with around 870 new cases every year (2017-2019).
  • In males in the UK, small intestine cancer is not among the 20 most common cancers, with around 1,100 new cases every year (2017-2019).
  • Incidence rates for small intestine cancer in the UK are highest in people aged 85 to 89 (2017-2019).
  • Each year around a third (34%) of all new small intestine cancer cases in the UK are diagnosed in people aged 75 and over (2017-2019).
  • Since the early 1990s, small intestine cancer incidence rates have increased by more than two-and-a-half times (176%) in the UK. Rates in females have increased by more than two-and-a-half times (176%), and rates in males have increased by more than two-and-a-half times (169%) (2017-2019).
  • Over the last decade, small intestine cancer incidence rates have increased by almost half (46%) in the UK. Rates in females have increased by almost half (46%), and rates in males have increased by more than two-fifths (43%) (2017-2019).
  • Small intestine cancer incidence rates are projected to rise by 44% in the UK between 2023-2025 and 2038-2040.
  • There could be around 4,500 new cases of small intestine cancer every year in the UK by 2038-2040, projections suggest.
  • The most common specific location for small intestine cancers in the UK is the duodenum (2016-2018).
  • Small intestine cancer incidence rates in England in females are similar in the most deprived quintile compared with the least, and in males are 22% higher in the most deprived quintile compared with the least (2013-2017).
  • Around 65 cases of small intestine cancer each year in males in England are linked with deprivation.
  • Incidence rates for small intestine cancer are lower in the Asian ethnic group, and similar in the Black ethnic group, compared with the White ethnic group, in England (2013-2017). See our publication Cancer Incidence by Broad Ethnic Group for more details.
  • There are around 560 small intestine cancer deaths in the UK every year, that's more than 1 every day (2017-2019).
  • Small intestine cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2017-2019).
  • In females in the UK, small intestine cancer is not among the 20 most common causes of cancer death, with around 260 deaths every year (2017-2019).
  • In males in the UK, small intestine cancer is the 19th most common cause of cancer death, with around 300 deaths every year (2017-2019).
  • Mortality rates for small intestine cancer in the UK are highest in people aged 85 to 89 (2017-2019).
  • Each year around half of all small intestine cancer deaths (49%) in the UK are in people aged 75 and over (2017-2019).
  • Since the early 1970s, small intestine cancer mortality rates have increased by almost half (45%) in the UK. Rates in females have increased by more than a third (36%), and rates in males have increased by almost three-fifths (55%) (2017-2019).
  • Over the last decade, small intestine cancer mortality rates have increased by around a quarter (26%) in the UK. Rates in females have increased by almost a third (31%), and rates in males have increased by around a fifth (19%) (2017-2019).
  • Small intestine cancer mortality rates are projected to rise by 1% in the UK between 2023-2025 and 2038-2040.
  • There could be around around 760 deaths of small intestine cancer every year in the UK by 2038-2040, projections suggest.
  • More than half (53.0%) of people diagnosed with small intestine cancer in England survive their disease for five years or more, it is predicted (2016-2020).
  • Small intestine cancer five-year survival in England is similar in females and males (2016-2020).
  • Around three-quarters (73.5%) of people in England diagnosed with small intestine cancer aged 15-44 survive their disease for five years or more, compared with around 4 in 10 (38.8%) people diagnosed aged 75-99 (2016-2020).
  • More than half of people in England diagnosed with small intestine cancer in the least deprived (54.3%) and most deprived (51.8%) groups survive their disease for five years or more (2015-2019).
  • Five-year relative survival for small intestine cancer is below or similar to the European average in the UK. Further details on cancer survival in Europe can be found on the EUROCARE website.
  • For small intestine cancer, like other cancer sites, survival trends reflect a combination of changes in treatment and stage distribution. These factors themselves can vary by age, sex and deprivation.
  • Further information on treatments for cancer can be found here.
  • Further one-, five- and ten-year survival statistics can be found on the Cancer Statistics Dashboard.
  • Nearly 1 in 250 UK females and 1 in 240 UK males will be diagnosed with small intenstine cancer in their lifetime (born in 1961).

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate Online 

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.